Carl C. Ward

Carl C. Ward

Auto-generated profile, based on publicly available information

Carl C. Ward

Gladstone–UCSF Institute of Genomic Immunology, San Francisco, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2022 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
NHNathaniel J. Henning
Nathaniel J. Henning
LBLydia Boike
Lydia Boike
JSJessica N. Spradlin
Jessica N. Spradlin
CWCarl C. Ward
Carl C. Ward
GLGang Liu
Gang Liu
DNDaniel K. Nomura
Daniel K. Nomura

13 December 2023 in Nature
Verified
Journal Article
Closed access
PDF file
RSRalf Schmidt
Ralf Schmidt
CWCarl C. Ward
Carl C. Ward
RDRama Dajani
Rama Dajani
ZAZev Armour-Garb
Zev Armour-Garb
MOMineto Ota
Mineto Ota
AMAlex Marson
Alex Marson

3 November 2023 in Science
Verified
Journal Article
Closed access
VPVanha N. Pham
Vanha N. Pham
KBKevin J. Bruemmer
Kevin J. Bruemmer
JTJoel D. W. Toh
Joel D. W. Toh
EGEva J. Ge
Eva J. Ge
LTLogan Tenney
Logan Tenney
CCChristopher J. Chang
Christopher J. Chang
One-carbon metabolism is an essential branch of cellular metabolism that intersects with epigenetic regulation. In this work, we show how formaldehyde (FA), a one-carbon unit derived from both endogenous sources and environmental exposure, regulates one-carbon metabolism by inhibiting the biosynthesis of S -adenosylmethionine (SAM), the major methyl donor in cells. FA reacts with privileged, hyperreactive cysteine sites in the proteome, including Cys120 in S-adenosylmethionine synthase isoform type-1 (MAT1A). FA exposure inhibited MAT1A activity and decreased SAM production with MAT-isoform specificity. A genetic mouse model of chronic FA overload showed a decrease n SAM and in methylation on selected histones and genes. Epigenetic and transcriptional regulation of Mat1a and related genes function as compensatory mechanisms for FA-dependent SAM depletion, revealing a biochemical feedback cycle between FA and SAM one-carbon units.

6 October 2025 in bioRxiv
Verified
Preprint
Open access
VAVincent Allain
Vincent Allain
ARAllison G. Rothrock
Allison G. Rothrock
PBPierre-Louis Bernard
Pierre-Louis Bernard
WNWilliam A. Nyberg
William A. Nyberg
ATAlexis Talbot
Alexis Talbot
JEJustin Eyquem
Justin Eyquem
Natural killer (NK) cells are emerging as a promising platform for engineered adoptive cell therapies. However, gene editing in NK cells remains challenging, and more effective strategies are needed. Here, we established a robust, feeder-free, and modular workflow for genome engineering in primary human NK cells, combining CRISPR/Cas9 with AAV6-mediated transgene delivery. Efficient site-specific transgene integration was achieved at various loci and can be coupled with concurrent disruption of the target locus in a single editing step. Furthermore, transgene expression was tunable according to the integration site and promoter. We applied this strategy to target a chimeric antigen receptor (CAR) transgene to a panel of inhibitory NK receptor loci, establishing a synergistic approach to enhance anti-tumor activity and facilitate the reliable comparison of CAR variants without expression bias. We identified TIGIT as an ideal locus that supports strong CAR expression and anti-tumor function. This genome engineering framework, which leverages multiple, complementary and precisely controlled genetic edits, can support the rational design of future NK-cell therapies tailored to overcome cell-intrinsic limitations and tumor-specific barriers.